[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 12 of about 12
1. Barsov EV, Payne WS, Hughes SH: Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range. J Virol; 2001 Jun;75(11):4973-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.
  • We have designed and characterized two new replication-competent avian sarcoma/leukosis virus-based retroviral vectors with amphotropic and ecotropic host ranges.
  • It replicates efficiently in avian DFJ8 cells that express murine ecotropic receptor.
  • For both vectors, permanent cell lines that produce viral stocks with titers of about 5 x 10(6) CFU/ml on mammalian cells can be easily established by passaging transfected avian cells.
  • For those chimeric viruses that do require modification, adaptation by passage in vitro or in vivo is a general strategy.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / genetics. Cell Line. Cells, Cultured. Chick Embryo. Leukemia Virus, Murine / genetics. Mice. Sequence Homology, Amino Acid. Viral Envelope Proteins / genetics. Virus Replication

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 1978 Apr;60(4):875-80 [204797.001]
  • [Cites] J Exp Med. 1978 Apr 1;147(4):1044-53 [206644.001]
  • [Cites] Acta Virol. 1978 Mar;22(2):91-6 [26209.001]
  • [Cites] Int J Cancer. 1979 Mar 15;23(3):415-23 [220198.001]
  • [Cites] Acta Virol. 1980 May;24(3):166-74 [6158852.001]
  • [Cites] Arch Virol. 1981;67(2):181-5 [6260064.001]
  • [Cites] Proc Soc Exp Biol Med. 1981 Sep;167(4):597-606 [6269117.001]
  • [Cites] Acta Med Okayama. 1983 Aug;37(4):273-82 [6312766.001]
  • [Cites] Gene. 1983 Nov;25(2-3):179-88 [6319235.001]
  • [Cites] Hum Gene Ther. 1998 Dec 10;9(18):2691-8 [9874267.001]
  • [Cites] Cell Biol Int. 1998;22(2):95-103 [9878096.001]
  • [Cites] Adv Exp Med Biol. 1998;451:423-30 [10026906.001]
  • [Cites] J Virol. 1999 Jul;73(7):6114-6 [10364368.001]
  • [Cites] Gene Ther. 1999 Aug;6(8):1456-68 [10467370.001]
  • [Cites] Proc Natl Acad Sci U S A. 1966 Oct;56(4):1164-9 [5230142.001]
  • [Cites] J Gen Virol. 1971 Nov;13(2):203-14 [5157829.001]
  • [Cites] J Natl Cancer Inst. 1973 Feb;50(2):381-5 [4349764.001]
  • [Cites] Virology. 1973 Apr;52(2):456-67 [4705382.001]
  • [Cites] J Natl Cancer Inst. 1975 Mar;54(3):763-66 [164569.001]
  • [Cites] Int J Cancer. 1975 May 15;15(5):849-59 [1140876.001]
  • [Cites] Bibl Haematol. 1975;(40):613-20 [169829.001]
  • [Cites] J Gen Virol. 1975 Oct;29(1):1-9 [171332.001]
  • [Cites] J Gen Virol. 1975 Oct;29(1):51-62 [171336.001]
  • [Cites] Virology. 1977 Feb;76(2):643-52 [65826.001]
  • [Cites] Virology. 1977 Feb;76(2):808-25 [190775.001]
  • [Cites] Virology. 1996 Sep 1;223(1):233-7 [8806557.001]
  • [Cites] Gene. 1996 Dec 5;182(1-2):145-50 [8982080.001]
  • [Cites] J Virol. 1997 Jun;71(6):4815-20 [9151877.001]
  • [Cites] Princess Takamatsu Symp. 1984;15:159-64 [6152758.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Jan;84(1):156-60 [3099292.001]
  • [Cites] Virology. 1988 Mar;163(1):43-51 [3126600.001]
  • [Cites] Biochem Biophys Res Commun. 1988 Feb 29;151(1):201-6 [3348773.001]
  • [Cites] Mol Cell Biol. 1989 Jan;9(1):100-8 [2927389.001]
  • [Cites] Cell. 1989 May 19;57(4):659-66 [2541919.001]
  • [Cites] Virology. 1989 Aug;171(2):331-41 [2503932.001]
  • [Cites] J Virol. 1989 Oct;63(10):4325-30 [2550668.001]
  • [Cites] J Virol. 1989 Nov;63(11):4857-65 [2795720.001]
  • [Cites] J Virol. 1990 May;64(5):2298-308 [1691314.001]
  • [Cites] AIDS Res Hum Retroviruses. 1990 Jun;6(6):707-20 [2364016.001]
  • [Cites] J Virol. 1990 Sep;64(9):4338-45 [2166820.001]
  • [Cites] J Virol. 1990 Oct;64(10):4661-71 [2204721.001]
  • [Cites] J Virol. 1991 Jan;65(1):162-9 [1845882.001]
  • [Cites] J Virol. 1991 Mar;65(3):1202-7 [1847450.001]
  • [Cites] J Virol. 1991 Jul;65(7):3728-37 [2041092.001]
  • [Cites] J Virol. 1991 Oct;65(10):5609-12 [1895408.001]
  • [Cites] J Virol. 1991 Nov;65(11):6129-36 [1717715.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):363-7 [1346069.001]
  • [Cites] Virology. 1992 Feb;186(2):792-4 [1733113.001]
  • [Cites] Arch Virol. 1992;125(1-4):287-98 [1642554.001]
  • [Cites] Nucleic Acids Res. 1992 Oct 11;20(19):5234 [1408844.001]
  • [Cites] J Virol. 1993 Jul;67(7):4142-53 [8389921.001]
  • [Cites] AIDS Res Hum Retroviruses. 1993 Aug;9(8):761-73 [8105835.001]
  • [Cites] J Virol. 1994 Jan;68(1):390-9 [7504739.001]
  • [Cites] J Virol Methods. 1993 Oct;44(2-3):287-304 [8263122.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):78-82 [8278411.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1168-72 [8302848.001]
  • [Cites] Virology. 1994 May 15;201(1):137-41 [8178478.001]
  • [Cites] Virology. 1994 Jul;202(1):471-6 [8009858.001]
  • [Cites] Res Virol. 1995 Jan-Feb;146(1):5-17 [7754236.001]
  • [Cites] J Virol. 1995 Nov;69(11):6618-26 [7474070.001]
  • [Cites] Nucleic Acids Res. 1996 Mar 1;24(5):979-80 [8600469.001]
  • [Cites] J Virol. 1996 Apr;70(4):2497-502 [8642678.001]
  • [Cites] J Virol. 1996 Mar;70(3):1340-54 [8627650.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] J Virol. 1996 Oct;70(10):6759-66 [8794313.001]
  • [Cites] Cancer Res. 1998 Aug 15;58(16):3519-25 [9721852.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1997 Jul;71(7):5663-7 [9188645.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8640-5 [9238030.001]
  • [Cites] Science. 1997 Sep 12;277(5332):1662-6 [9287219.001]
  • [Cites] Blood. 1997 Dec 1;90(11):4638-45 [9373277.001]
  • [Cites] AIDS. 1997 Nov 15;11(14):1681-8 [9386802.001]
  • [Cites] J Virol. 1998 Feb;72(2):1115-21 [9445007.001]
  • [Cites] Hum Gene Ther. 1998 Jan 20;9(2):225-34 [9472782.001]
  • [Cites] J Virol. 1998 Apr;72(4):2686-96 [9525586.001]
  • [Cites] Gene Ther. 1998 Feb;5(2):209-17 [9578840.001]
  • [Cites] J Virol Methods. 1998 Jul;73(1):31-9 [9705172.001]
  • [Cites] Virology. 1977 Feb;76(2):826-34 [65828.001]
  • [Cites] J Virol. 1977 Mar;21(3):1252-5 [191647.001]
  • [Cites] J Virol. 1977 Mar;21(3):965-73 [191655.001]
  • [Cites] Cancer Res. 1977 Jun;37(6):1768-76 [192461.001]
  • [Cites] Virology. 1977 Oct 1;82(1):221-31 [197701.001]
  • (PMID = 11333876.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Viral Envelope Proteins
  • [Other-IDs] NLM/ PMC114900
  •  go-up   go-down


2. Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X: Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol; 2007 Jun;81(12):6731-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.
  • On the other hand, integration of avian sarcoma-leukosis virus (ASLV) shows little preference either for genes, transcription start sites, or CpG islands.
  • Although integration profiles are well defined for members of the lentivirus, spumaretrovirus, alpharetrovirus, and gammaretrovirus genera, no members of the deltaretroviruses, for example, human T-cell leukemia virus type 1 (HTLV-1), have been evaluated.
  • Our results suggest that the global integration profiles of other retroviruses could be predicted from phylogenetic comparisons of the integrase proteins.

  • Genetic Alliance. consumer health - Human T-cell leukemia virus type 1.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Mar;74(5):2305-12 [10666261.001]
  • [Cites] Nature. 2005 Feb 10;433(7026):561 [15703711.001]
  • [Cites] Mol Cell Biol. 2001 Apr;21(7):2393-403 [11259588.001]
  • [Cites] J Virol. 2001 Sep;75(18):8461-8 [11507191.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Mol Ther. 2002 Nov;6(5):570-1 [12409254.001]
  • [Cites] Eukaryot Cell. 2002 Feb;1(1):44-55 [12455970.001]
  • [Cites] J Biol Chem. 2003 Jan 3;278(1):372-81 [12407101.001]
  • [Cites] N Engl J Med. 2003 Jan 16;348(3):255-6 [12529469.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] J Virol. 2005 Apr;79(8):5211-4 [15795304.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • [Cites] Hum Gene Ther. 2005 Apr;16(4):522-6 [15871683.001]
  • [Cites] Blood. 2005 Aug 1;106(3):1048-53 [15840694.001]
  • [Cites] J Virol. 2005 Oct;79(19):12199-204 [16160146.001]
  • [Cites] Nat Rev Microbiol. 2005 Nov;3(11):848-58 [16175173.001]
  • [Cites] Nat Med. 2005 Dec;11(12):1287-9 [16311605.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] Genome Res. 2006 Jan;16(1):123-31 [16344561.001]
  • [Cites] Mol Ther. 2006 Feb;13(2):366-73 [16325473.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1498-503 [16428288.001]
  • [Cites] J Gen Virol. 2006 May;87(Pt 5):1339-47 [16603537.001]
  • [Cites] PLoS Pathog. 2006 Jun;2(6):e60 [16789841.001]
  • [Cites] Mol Ther. 2006 Aug;14(2):218-25 [16647883.001]
  • [Cites] J Virol. 2006 Sep;80(17):8820-3 [16912328.001]
  • [Cites] J Virol. 2006 Oct;80(19):9497-510 [16973554.001]
  • [Cites] Science. 2006 Oct 20;314(5798):461-4 [16959972.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):113-24 [17158150.001]
  • [Cites] Genome Res. 2003 Sep;13(9):1984-97 [12952871.001]
  • [Cites] Science. 2003 Oct 17;302(5644):415-9 [14564000.001]
  • [Cites] Cell. 2003 Oct 17;115(2):135-8 [14567911.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):992-7 [14732688.001]
  • [Cites] J Hum Genet. 2004;49(3):154-65 [14991527.001]
  • [Cites] Cancer Sci. 2004 Apr;95(4):306-10 [15072587.001]
  • [Cites] Brief Bioinform. 2004 Jun;5(2):150-63 [15260895.001]
  • [Cites] J Virol. 2004 Sep;78(17):9524-37 [15308744.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Front Biosci. 2004 Sep 1;9:3187-208 [15353349.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Nature. 1986 May 15-21;321(6067):209-13 [2423876.001]
  • [Cites] Annu Rev Biochem. 1988;57:159-97 [3052270.001]
  • [Cites] Curr Top Microbiol Immunol. 1990;157:1-18 [2203607.001]
  • [Cites] Mol Cell Biol. 1990 Dec;10(12):6791-8 [2174117.001]
  • [Cites] EMBO J. 1992 Jan;11(1):291-303 [1310932.001]
  • [Cites] Cell. 1992 May 29;69(5):769-80 [1317268.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5532-6 [1319063.001]
  • [Cites] Genomics. 1992 Aug;13(4):1095-107 [1505946.001]
  • [Cites] Genes Dev. 1994 Jun 15;8(12):1473-87 [7926746.001]
  • [Cites] Biokhimiia. 1995 Aug;60(8):1221-30 [7578577.001]
  • [Cites] Annu Rev Immunol. 1997;15:15-37 [9143680.001]
  • [Cites] Nat Med. 1998 Mar;4(3):354-7 [9500613.001]
  • [Cites] J Virol. 1999 Jun;73(6):5186-90 [10233986.001]
  • [Cites] Lancet. 1999 Jun 5;353(9168):1951-8 [10371587.001]
  • [Cites] Cell Mol Life Sci. 2004 Oct;61(19-20):2588-96 [15526164.001]
  • [Cites] PLoS Biol. 2004 Dec;2(12):e423 [15550989.001]
  • [Cites] J Biol Chem. 2004 Dec 31;279(53):55570-7 [15475359.001]
  • [Cites] AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1653-9 [11080806.001]
  • (PMID = 17409138.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1900082
  •  go-up   go-down


3. Somia N: Gene transfer by retroviral vectors: an overview. Methods Mol Biol; 2004;246:463-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this respect, retroviruses came to the fore in the early 1900s with the demonstration by Ellermann and Bang and by Rous that chicken leukosis was caused by a virus, now referred to as avian sarcoma/leukosis virus (ASLV).
  • This began a body of work that led to the identification of virus-induced tumors in mammalian species and retroviruses (as they are now called) were identified as the causative agents for a number of pathologies from tumors to acquired immunodefiencey syndrome (AIDS).
  • The study of retroviruses contributed and led to the elucidation of a number of diverse biological phenomena as the oncogenes carried by these viruses began to be identified as receptors, kinases, and transcription factors (3).
  • The idea that these viruses could be used to ferry a gene of choice, rather than the viral genome, springs from the study of Rous sarcoma virus (RSV).
  • [MeSH-minor] Animals. Humans. Transcription, Genetic. Virus Integration. Virus Replication

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14970611.001).
  • [ISSN] 1064-3745
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 120
  •  go-up   go-down


Advertisement
4. Hatai H, Ochiai K, Nagakura K, Imanishi S, Ochi A, Kozakura R, Ono M, Goryo M, Ohashi K, Umemura T: A recombinant avian leukosis virus associated with fowl glioma in layer chickens in Japan. Avian Pathol; 2008 Apr;37(2):127-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A recombinant avian leukosis virus associated with fowl glioma in layer chickens in Japan.
  • Fowl glioma is characterized by multiple nodular growth of astrocytes, and fowl glioma-inducing virus belonging to avian leukosis virus has been isolated from Japanese bantam as a causal agent.
  • The genome of one isolate mainly consisted of ev loci and contained several parts of other avian leukosis/sarcoma viruses.
  • These results show that the causal avian leukosis virus of fowl glioma is not just fowl glioma-inducing virus and that different avian leukosis virus strains having oncogenicity in the central nervous system by recombination are spread in layers in Japan.
  • [MeSH-major] Avian Leukosis / virology. Avian Leukosis Virus / classification. Chickens / virology. Glioma / veterinary. Reassortant Viruses
  • [MeSH-minor] Animals. Female. Japan / epidemiology. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / veterinary. Soft Tissue Neoplasms / virology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18393089.001).
  • [ISSN] 1465-3338
  • [Journal-full-title] Avian pathology : journal of the W.V.P.A
  • [ISO-abbreviation] Avian Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


5. Amberg SM, Netter RC, Simmons G, Bates P: Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide. J Virol; 2006 Jan;80(1):353-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The envelope of class I viruses can be a target for potent viral inhibitors, such as the human immunodeficiency virus type 1 (HIV-1) inhibitor enfuvirtide, which are derived from the C-terminal heptad repeat (HR2) of the transmembrane (TM) subunit.
  • Resistance to an HR2-based peptide inhibitor of a model retrovirus, subgroup A of the Avian Sarcoma and Leukosis Virus genus (ASLV-A), was studied by examining mutants derived by viral passage in the presence of inhibitor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2002 Jan;76(1):178-84 [11739683.001]
  • [Cites] J Virol. 2005 Apr;79(8):4991-9 [15795284.001]
  • [Cites] J Virol. 2002 Mar;76(6):2595-605 [11861825.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 [12019106.001]
  • [Cites] Trends Cell Biol. 2002 Jun;12(6):273-80 [12074887.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] BMC Microbiol. 2001;1:1 [11208257.001]
  • [Cites] J Virol. 2002 Nov;76(22):11186-98 [12388678.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54 [12444251.001]
  • [Cites] AIDS. 2003 Feb 14;17(3):291-300 [12556682.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] J Virol. 2003 Mar;77(5):3281-90 [12584351.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] J Virol. 2003 Jun;77(12):6709-19 [12767991.001]
  • [Cites] Biochim Biophys Acta. 2003 Jul 11;1614(1):116-21 [12873772.001]
  • [Cites] J Virol. 2003 Aug;77(16):8801-11 [12885899.001]
  • [Cites] Oncogene. 2003 Sep 11;22(39):7931-41 [12970741.001]
  • [Cites] J Gen Virol. 2003 Dec;84(Pt 12):3233-8 [14645905.001]
  • [Cites] J Gen Virol. 2004 Mar;85(Pt 3):647-52 [14993650.001]
  • [Cites] Nat Rev Drug Discov. 2004 Mar;3(3):215-25 [15031735.001]
  • [Cites] Lancet. 2004 Mar 20;363(9413):938-47 [15043961.001]
  • [Cites] J Virol. 2004 May;78(9):4628-37 [15078945.001]
  • [Cites] J Virol. 2004 May;78(10):5476-85 [15113926.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60 [15150417.001]
  • [Cites] J Virol. 2004 Jul;78(14):7582-9 [15220433.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] J Antimicrob Chemother. 2004 Aug;54(2):333-40 [15231762.001]
  • [Cites] Virology. 1986 May;151(1):139-45 [3008429.001]
  • [Cites] Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 [2631796.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10537-41 [1438243.001]
  • [Cites] FEBS Lett. 1992 Jul 6;305(3):181-4 [1299611.001]
  • [Cites] Nature. 1993 Sep 9;365(6442):113 [8371754.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1994 Sep;68(9):5623-8 [8057442.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 [7937889.001]
  • [Cites] Nucleic Acids Res. 1995 Feb 25;23(4):628-33 [7899083.001]
  • [Cites] J Virol. 2000 Sep;74(18):8358-67 [10954535.001]
  • [Cites] J Virol. 2000 Oct;74(20):9738-41 [11000247.001]
  • [Cites] J Virol. 2000 Nov;74(21):10194-201 [11024148.001]
  • [Cites] J Virol. 2001 Mar;75(5):2041-50 [11160708.001]
  • [Cites] J Virol. 2001 Apr;75(8):3568-80 [11264346.001]
  • [Cites] J Virol. 2001 Apr;75(8):3903-15 [11264379.001]
  • [Cites] Curr Opin Microbiol. 2001 Aug;4(4):450-5 [11495810.001]
  • [Cites] J Virol. 2001 Sep;75(18):8605-14 [11507206.001]
  • [Cites] J Virol. 1995 Dec;69(12):7410-5 [7494245.001]
  • [Cites] EMBO J. 1995 Nov 15;14(22):5524-31 [8521809.001]
  • [Cites] J Virol. 1996 Mar;70(3):1564-9 [8627675.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91 [8700906.001]
  • [Cites] J Virol. 1996 Nov;70(11):7510-6 [8892869.001]
  • [Cites] J Virol. 1997 Feb;71(2):1453-65 [8995671.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14306-13 [9405608.001]
  • [Cites] J Virol. 1998 Feb;72(2):986-93 [9444991.001]
  • [Cites] J Virol. 1998 Apr;72(4):3155-60 [9525641.001]
  • [Cites] J Virol. 1998 Apr;72(4):3259-67 [9525653.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8467-72 [9671701.001]
  • [Cites] Mol Cell. 1998 Nov;2(5):605-16 [9844633.001]
  • [Cites] J Virol. 1999 Apr;73(4):3054-61 [10074155.001]
  • [Cites] J Virol. 1999 Apr;73(4):3087-94 [10074159.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7 [10077567.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6359-64 [10339592.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] J Virol. 2002 Jan;76(2):644-55 [11752155.001]
  • (PMID = 16352560.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01-CA76256; United States / NIAID NIH HHS / AI / F32-AI050341; United States / NIAID NIH HHS / AI / R01 AI043455; United States / NIAID NIH HHS / AI / F32 AI050341; United States / NIGMS NIH HHS / GM / T32 GM007229; United States / NIAID NIH HHS / AI / R01-AI43455; United States / NCI NIH HHS / CA / R01 CA076256; United States / NIGMS NIH HHS / GM / T32-GM07229
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Peptides; 0 / Viral Envelope Proteins; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC1317511
  •  go-up   go-down


6. Shahabuddin M, Sears JF, Khan AS: No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures. J Clin Microbiol; 2001 Feb;39(2):675-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.
  • All vaccines that are prepared in chicken embryo fibroblasts (CEFs) contain a low level of particle-associated reverse transcriptase (RT) activity, which is produced from the avian cell substrate.
  • The RNAs present in the particles have sequence homology to viral DNAs belonging to the ancient endogenous avian virus (EAV) family or to the avian sarcoma-leukosis virus (ALV)-related subgroup E endogenous virus loci.
  • To address these possibilities, we have analyzed EAV and ALV particles in a measles virus vaccine equivalent (MVVE) preparation, obtained from a U.S. manufacturer, for integration and for replication in human peripheral blood mononuclear cells (PBMCs).
  • These results provide further confidence regarding the safety of chicken RT activity in live viral vaccines and support the continued use of chick-cell-derived vaccines in humans.
  • [MeSH-major] Measles Vaccine. Retroviridae / isolation & purification. Vaccines, Attenuated
  • [MeSH-minor] Alpharetrovirus / isolation & purification. Animals. Base Sequence. Cells, Cultured. Chick Embryo. DNA Primers. DNA, Viral / analysis. Drug Contamination. Endogenous Retroviruses / isolation & purification. Humans. Lymphocytes / virology. Molecular Sequence Data. Oligonucleotide Probes. Polymerase Chain Reaction / methods. RNA, Viral / analysis. Reverse Transcriptase Polymerase Chain Reaction. Safety. Sensitivity and Specificity. Virus Integration. Virus Replication

  • Genetic Alliance. consumer health - Measles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 1969 Jul;38(3):414-26 [4308055.001]
  • [Cites] J Virol. 1992 Apr;66(4):2232-9 [1548759.001]
  • [Cites] J Virol. 1976 Jul;19(1):13-8 [181592.001]
  • [Cites] J Virol. 1976 Jul;19(1):19-25 [59816.001]
  • [Cites] Virology. 1977 Feb;76(2):808-25 [190775.001]
  • [Cites] Exp Cell Res. 1978 Dec;117(2):383-92 [82515.001]
  • [Cites] Virology. 1981 Jan 15;108(1):189-207 [6267771.001]
  • [Cites] Proc Soc Exp Biol Med. 1982 Jul;170(3):350-8 [6283561.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Arch Virol. 1983;75(4):307-11 [6301409.001]
  • [Cites] J Virol. 1992 Aug;66(8):4919-29 [1321278.001]
  • [Cites] Ann Neurol. 1992 Sep;32(3):401-4 [1416811.001]
  • [Cites] Nat Genet. 1992 Jun;1(3):222-5 [1303240.001]
  • [Cites] Genomics. 1995 Sep 20;29(2):403-8 [8666388.001]
  • [Cites] J Virol. 1997 Apr;71(4):3005-12 [9060660.001]
  • [Cites] Gene. 1997 Sep 15;197(1-2):305-9 [9332379.001]
  • [Cites] FEBS Lett. 1997 Nov 3;417(1):1-5 [9395063.001]
  • [Cites] Biologicals. 1997 Dec;25(4):403-14 [9467036.001]
  • [Cites] Wkly Epidemiol Rec. 1998 Jul 10;73(28):209-12 [9677853.001]
  • [Cites] MMWR Recomm Rep. 1998 Jul 24;47(RR-11):1-23 [9692935.001]
  • [Cites] J Clin Virol. 1998 Jul 24;11(1):7-18 [9784139.001]
  • [Cites] J Clin Virol. 1998 Jul 24;11(1):19-28 [9784140.001]
  • [Cites] Biotechniques. 1998 Dec;25(6):972-5 [9863050.001]
  • [Cites] J Virol. 1999 Jul;73(7):5345-55 [10364281.001]
  • [Cites] J Virol. 1999 Jul;73(7):5843-51 [10364336.001]
  • [Cites] J Clin Microbiol. 1999 Aug;37(8):2678-86 [10405421.001]
  • [Cites] Virology. 1983 Apr 15;126(1):51-72 [6302996.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Aug;82(15):5097-101 [2410912.001]
  • [Cites] J Virol. 1986 Sep;59(3):669-75 [3016330.001]
  • [Cites] Virology. 1989 Nov;173(1):157-66 [2815581.001]
  • [Cites] J Virol. 1990 Feb;64(2):757-66 [2153240.001]
  • [Cites] Virology. 1990 May;176(1):58-69 [1691887.001]
  • [Cites] J Virol. 1990 Oct;64(10):4640-53 [2398526.001]
  • [Cites] J Virol. 1975 Jul;16(1):146-52 [48558.001]
  • (PMID = 11158127.001).
  • [ISSN] 0095-1137
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral; 0 / Measles Vaccine; 0 / Oligonucleotide Probes; 0 / RNA, Viral; 0 / Vaccines, Attenuated
  • [Other-IDs] NLM/ PMC87796
  •  go-up   go-down


7. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS: Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell; 2003 Jan;3(1):23-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Kaposi's sarcoma herpesvirus (KSHV) has been identified as the etiologic agent of Kaposi's sarcoma (KS), but initial events leading to KS development remain unclear.
  • [MeSH-major] Cell Transformation, Neoplastic. Herpesvirus 8, Human / genetics. Proto-Oncogene Proteins. Receptors, Chemokine / metabolism. Sarcoma, Kaposi / virology. Viral Proteins / metabolism
  • [MeSH-minor] Animals. Avian Leukosis Virus / genetics. Cells, Cultured. Endothelium, Vascular / physiology. Endothelium, Vascular / ultrastructure. Endothelium, Vascular / virology. Genetic Engineering / methods. Immunohistochemistry. Mice. Mice, Transgenic. Microscopy, Electron. Neoplasm Proteins / genetics. Promoter Regions, Genetic. Transduction, Genetic

  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer Cell. 2003 Jan;3(1):1-3 [12559168.001]
  • (PMID = 12559173.001).
  • [ISSN] 1535-6108
  • [Journal-full-title] Cancer cell
  • [ISO-abbreviation] Cancer Cell
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / 2R0-1 DK 49414; United States / NHLBI NIH HHS / HL / 2R0-1 HL 55605; United States / NIAID NIH HHS / AI / R0-1 AI46145-01A2
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MEN1 protein, human; 0 / Neoplasm Proteins; 0 / ORF74 protein, Human herpesvirus 8; 0 / Proto-Oncogene Proteins; 0 / Receptors, Chemokine; 0 / Viral Proteins
  •  go-up   go-down


8. Chang KW, Barsov EV, Ferris AL, Hughes SH: Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors. J Virol; 2005 Aug;79(16):10258-67
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors.
  • Previous attempts to extend the host range of the avian sarcoma/leukosis virus (ASLV)-based RCASBP vectors produced two viral vectors, RCASBP M2C (4070A) and RCASBP M2C (797-8), which replicate using the amphotropic murine leukemia virus 4070A Env protein (2).
  • Both viruses were adapted to replicate efficiently in the avian cell line DF-1, but RCASBP M2C (4070A) caused extensive cytopathic effects (CPE) in DF-1 cells whereas RCASBP M2C (797-8) induced low levels of CPE.
  • In RCASBP M2C (4070A), an isoleucine replaced the wild-type proline residue, whereas a threonine residue was found in RCASBP M2C (797-8).
  • [MeSH-major] Cytopathogenic Effect, Viral. Gene Products, env / chemistry. Orthoreovirus, Avian / physiology. Virus Replication
  • [MeSH-minor] Animals. Calcium / metabolism. Cell Line. Chick Embryo. DNA, Viral / analysis. Dantrolene / pharmacology. Endoplasmic Reticulum / metabolism. Genetic Vectors. Peptides

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DANTROLENE .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurochem. 2000 Jul;75(1):81-90 [10854250.001]
  • [Cites] J Virol. 1998 Dec;72(12):9955-65 [9811733.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] J Virol. 2001 Jul;75(13):6007-15 [11390602.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] J Virol. 2002 Oct;76(19):9673-85 [12208946.001]
  • [Cites] Mamm Genome. 2002 Oct;13(10):543-7 [12420130.001]
  • [Cites] Biochem Biophys Res Commun. 2003 May 9;304(3):445-54 [12729578.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jul;4(7):552-65 [12838338.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8764-9 [12857957.001]
  • [Cites] Nat Rev Neurosci. 2003 Aug;4(8):672-84 [12894242.001]
  • [Cites] J Virol. 2003 Oct;77(20):10841-9 [14512534.001]
  • [Cites] J Virol. 2003 Dec;77(23):12552-61 [14610178.001]
  • [Cites] J Mol Biol. 1967 Jun 14;26(2):365-9 [4291934.001]
  • [Cites] Virology. 1973 Apr;52(2):456-67 [4705382.001]
  • [Cites] J Virol. 1979 Aug;31(2):376-88 [225560.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] J Virol. 1981 Sep;39(3):713-21 [6270346.001]
  • [Cites] Virology. 1982 Jan 30;116(2):499-516 [6175079.001]
  • [Cites] Nature. 1986 Jan 23-29;319(6051):333-6 [3001539.001]
  • [Cites] J Virol. 1990 Oct;64(10):4836-41 [2398529.001]
  • [Cites] J Exp Med. 1990 Oct 1;172(4):1035-42 [2212939.001]
  • [Cites] J Virol. 1990 Dec;64(12):6176-83 [1700832.001]
  • [Cites] J Virol. 1992 Mar;66(3):1468-75 [1310758.001]
  • [Cites] J Virol. 1993 Jun;67(6):3489-96 [7684467.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] J Virol. 1997 Nov;71(11):8103-8 [9343159.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Virol. 1998 Jul;72(7):5383-91 [9620992.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 2001 May;75(9):4357-66 [11287584.001]
  • (PMID = 16051819.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Gene Products, env; 0 / Peptides; 25191-13-3 / polyproline; F64QU97QCR / Dantrolene; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ PMC1182669
  •  go-up   go-down


9. Hu J, Renaud G, Golmes T, Ferris A, Hendrie PC, Donahue RE, Hughes SH, Wolfsberg TG, Russell DW, Dunbar CE: Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors. Mol Ther; 2008 Sep;16(9):1617-1623
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors.
  • In this study, we report for the first time a systematic analysis of 198 avian sarcoma leukosis virus (ASLV) insertion sites identified in rhesus long-term repopulating cells, and a comparison of ASLV insertion patterns to Moloney murine leukemia virus (MLV) (n = 396) and simian immunodeficiency virus (SIV) (n = 289) using the newly released rhesus genome databank.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2008 The American Society of Gene Therapy. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28189014.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Barnard RJ, Narayan S, Dornadula G, Miller MD, Young JA: Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. J Virol; 2004 Oct;78(19):10433-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.
  • A novel entry mechanism has been proposed for the avian sarcoma and leukosis virus (ASLV), whereby interaction with specific cell surface receptors activates or primes the viral envelope glycoprotein (Env), rendering it sensitive to subsequent low-pH-dependent fusion triggering in acidic intracellular organelles.
  • To address this possibility, hybrid virus particles were generated with the core of human immunodeficiency virus type 1 (HIV-1), a known pH-independent virus, and with subgroups A or B ASLV Env proteins.
  • Infection of cells by these pseudotyped virions was blocked by lysosomotropic agents, as judged by inhibition of HIV-1 DNA synthesis.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Apr;74(8):3548-54 [10729129.001]
  • [Cites] Virology. 1998 Aug 15;248(1):20-34 [9705252.001]
  • [Cites] J Virol. 2000 Jun;74(11):5066-74 [10799580.001]
  • [Cites] Annu Rev Biochem. 2000;69:531-69 [10966468.001]
  • [Cites] J Virol. 2000 Oct;74(20):9381-7 [11000206.001]
  • [Cites] J Cell Biol. 2000 Oct 16;151(2):413-23 [11038187.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] J Virol. 2001 Apr;75(8):4014-8 [11264394.001]
  • [Cites] J Virol. 2001 Oct;75(19):9339-44 [11533197.001]
  • [Cites] Annu Rev Biochem. 2001;70:777-810 [11395423.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] Cell. 1999 Apr 16;97(2):165-74 [10219238.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72 [10449786.001]
  • [Cites] J Virol. 2000 Apr;74(8):3572-78 [10729132.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13843-8 [12368468.001]
  • [Cites] Nat Biotechnol. 2002 Nov;20(11):1151-4 [12355096.001]
  • [Cites] J Virol. 2002 Dec;76(24):12866-76 [12438612.001]
  • [Cites] J Virol. 2003 Feb;77(3):1977-83 [12525631.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6 [12761383.001]
  • [Cites] Mol Biol Cell. 2003 Aug;14(8):3305-24 [12925765.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;281:107-36 [12932076.001]
  • [Cites] J Virol. 2003 Oct;77(19):10645-50 [12970449.001]
  • [Cites] J Virol. 2004 Feb;78(3):1403-10 [14722295.001]
  • [Cites] J Virol. 2004 Apr;78(7):3753-62 [15016895.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 18;101(20):7721-6 [15128947.001]
  • [Cites] Cell. 1987 Jun 5;49(5):659-68 [3107838.001]
  • [Cites] EMBO J. 1988 Feb;7(2):513-8 [3259178.001]
  • [Cites] J Virol. 1990 Oct;64(10):5106-13 [2168989.001]
  • [Cites] J Biol Chem. 1991 Sep 25;266(27):18404-10 [1917964.001]
  • [Cites] Cell. 1992 May 1;69(3):517-28 [1374685.001]
  • [Cites] Cell. 1992 May 15;69(4):577-8 [1375129.001]
  • [Cites] J Virol. 1992 Aug;66(8):4966-71 [1629961.001]
  • [Cites] J Virol. 1992 Dec;66(12):7309-18 [1433520.001]
  • [Cites] J Biol Chem. 1995 Jul 21;270(29):17575-81 [7615563.001]
  • [Cites] J Virol. 1995 Dec;69(12):7410-5 [7494245.001]
  • [Cites] J Virol. 1996 Jan;70(1):341-51 [8523546.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] Nature. 1996 Jun 20;381(6584):661-6 [8649511.001]
  • [Cites] J Biol Chem. 1996 Jun 7;271(23):13417-21 [8662770.001]
  • [Cites] J Virol. 1996 Nov;70(11):7510-6 [8892869.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] Annu Rev Cell Dev Biol. 1996;12:627-61 [8970739.001]
  • [Cites] J Cell Biol. 1997 Dec 15;139(6):1455-64 [9396751.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7 [9861018.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] J Virol. 1998 Apr;72(4):3155-60 [9525641.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7063-8 [9618539.001]
  • [Cites] J Virol. 2000 Apr;74(8):3859-70 [10729160.001]
  • (PMID = 15367609.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA070810; United States / NCI NIH HHS / CA / CA70810
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Gene Products, env; 0 / Receptors, Virus; EC 3.5.2.6 / beta-Lactamases
  • [Other-IDs] NLM/ PMC516436
  •  go-up   go-down


11. Markosyan RM, Bates P, Cohen FS, Melikyan GB: A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. Biophys J; 2004 Nov;87(5):3291-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.
  • The fusion protein of avian sarcoma and leukosis virus is likely to fold into a six-helix bundle as part of its final configuration.
  • The stages at which the envelope protein (Env) of avian sarcoma and leukosis virus subgroup A folds into a bundle during low pH-induced fusion were determined.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Biol. 1996 Dec;135(6 Pt 2):1831-9 [8991094.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91 [8700906.001]
  • [Cites] Curr Biol. 1997 Sep 1;7(9):R565-9 [9285698.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] J Cell Biol. 1998 Mar 23;140(6):1369-82 [9508770.001]
  • [Cites] Cell. 1998 May 29;93(5):681-4 [9630213.001]
  • [Cites] Mol Cell. 1998 Nov;2(5):605-16 [9844633.001]
  • [Cites] Cell. 1998 Dec 23;95(7):871-4 [9875840.001]
  • [Cites] J Virol. 1999 Apr;73(4):3054-61 [10074155.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7 [10077567.001]
  • [Cites] Mol Cell. 1999 Mar;3(3):309-19 [10198633.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8967-72 [10430879.001]
  • [Cites] J Cell Biol. 1997 Dec 15;139(6):1455-64 [9396751.001]
  • [Cites] J Virol. 2000 Jul;74(14):6469-75 [10864659.001]
  • [Cites] J Cell Biol. 2000 Oct 16;151(2):413-23 [11038187.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] Biophys J. 2001 Feb;80(2):812-21 [11159448.001]
  • [Cites] EMBO J. 2001 Aug 1;20(15):4024-34 [11483506.001]
  • [Cites] Annu Rev Biochem. 2001;70:777-810 [11395423.001]
  • [Cites] Virology. 2002 Oct 10;302(1):174-84 [12429526.001]
  • [Cites] J Virol. 2002 Dec;76(24):12866-76 [12438612.001]
  • [Cites] J Virol. 2003 Feb;77(3):1977-83 [12525631.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] J Virol. 2003 Mar;77(5):3281-90 [12584351.001]
  • [Cites] Mol Biol Cell. 2003 Mar;14(3):926-38 [12631714.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] Nat Struct Biol. 2003 Dec;10(12):1048-53 [14595397.001]
  • [Cites] Virology. 2003 Nov 25;316(2):234-44 [14644606.001]
  • [Cites] J Virol. 2004 Feb;78(3):1403-10 [14722295.001]
  • [Cites] Nature. 2004 Jan 22;427(6972):313-9 [14737159.001]
  • [Cites] Nature. 2004 Jan 22;427(6972):320-5 [14737160.001]
  • [Cites] EMBO J. 2004 Feb 25;23(4):728-38 [14963486.001]
  • [Cites] J Virol. 2004 Apr;78(7):3753-62 [15016895.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] Biochemistry. 1984 Nov 20;23(24):5675-81 [6098295.001]
  • [Cites] Biochemistry. 1988 Jan 12;27(1):30-6 [2831956.001]
  • [Cites] EMBO J. 1993 Feb;12(2):693-701 [8440260.001]
  • [Cites] Nature. 1993 Sep 9;365(6442):113 [8371754.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 [7937889.001]
  • [Cites] J Membr Biol. 1995 Jul;146(1):1-14 [7563032.001]
  • [Cites] Nat Struct Biol. 1995 Dec;2(12):1075-82 [8846219.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] Nature. 1997 May 22;387(6631):426-30 [9163431.001]
  • (PMID = 15339808.001).
  • [ISSN] 0006-3495
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM027367; United States / NIAID NIH HHS / AI / R01 AI043455; United States / NIAID NIH HHS / AI / AI43455; United States / NIGMS NIH HHS / GM / GM27367; United States / NCI NIH HHS / CA / CA76256; United States / NIAID NIH HHS / AI / R01 AI053668; United States / NCI NIH HHS / CA / R01 CA076256; United States / NIAID NIH HHS / AI / AI053668
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Peptides
  • [Other-IDs] NLM/ PMC1304797
  •  go-up   go-down


12. Matsuyama S, Delos SE, White JM: Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein. J Virol; 2004 Aug;78(15):8201-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A general model has been proposed for the fusion mechanisms of class I viral fusion proteins.
  • While there is ample biochemical and structural information on the trimer-of-hairpins conformation of class I viral fusion proteins, less is known about intermediate states between native metastable trimers and the final trimer of hairpins.
  • In this study we analyzed conformational states of the transmembrane subunit (TM), the fusion subunit, of the Env glycoprotein of the subtype A avian sarcoma and leukosis virus (ASLV-A).
  • Following subsequent exposure to a low pH (or an elevated temperature or the fusion promoting agent chlorpromazine), an additional set of bands at >150 kDa, and then a final band at 100 kDa, forms.
  • Both an EnvA C-helix peptide (which inhibits virus fusion and infectivity) and the fusion-inhibitory agent lysophosphatidylcholine inhibit the formation of the >150- and 100-kDa bands.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jan;74(1):447-55 [10590134.001]
  • [Cites] Mol Biol Cell. 2000 Apr;11(4):1143-52 [10749920.001]
  • [Cites] Virology. 2000 Apr 25;270(1):17-30 [10772976.001]
  • [Cites] J Virol. 2000 Jul;74(14):6614-21 [10864675.001]
  • [Cites] Mol Biol Cell. 2000 Jul;11(7):2359-71 [10888674.001]
  • [Cites] J Virol. 2000 Aug;74(16):7529-37 [10906206.001]
  • [Cites] Annu Rev Biochem. 2000;69:531-69 [10966468.001]
  • [Cites] J Virol. 2000 Oct;74(20):9738-41 [11000247.001]
  • [Cites] J Cell Biol. 2000 Oct 16;151(2):413-23 [11038187.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] J Virol. 2001 Mar;75(5):2337-44 [11160737.001]
  • [Cites] J Virol. 2001 Apr;75(8):4014-8 [11264394.001]
  • [Cites] J Virol. 2001 Jun;75(11):5363-9 [11333918.001]
  • [Cites] EMBO J. 2001 Aug 1;20(15):4024-34 [11483506.001]
  • [Cites] Virology. 2001 Oct 25;289(2):343-52 [11689056.001]
  • [Cites] J Cell Biol. 2001 Nov 26;155(5):833-44 [11724823.001]
  • [Cites] FEBS Lett. 2001 Dec 7;509(2):161-8 [11768384.001]
  • [Cites] Annu Rev Biochem. 2001;70:777-810 [11395423.001]
  • [Cites] J Virol. 2002 Mar;76(6):2683-91 [11861835.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] J Cell Biol. 1996 May;133(3):559-69 [8636231.001]
  • [Cites] J Cell Biol. 1996 Oct;135(1):63-71 [8858163.001]
  • [Cites] J Cell Biol. 1997 Dec 15;139(6):1455-64 [9396751.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14306-13 [9405608.001]
  • [Cites] J Virol. 1998 Apr;72(4):3259-67 [9525653.001]
  • [Cites] Nat Struct Biol. 1998 Apr;5(4):276-9 [9546217.001]
  • [Cites] J Virol. 1998 Oct;72(10):7745-53 [9733810.001]
  • [Cites] J Virol. 1998 Dec;72(12):9645-55 [9811698.001]
  • [Cites] J Gen Virol. 2002 Sep;83(Pt 9):2241-6 [12185279.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12386-90 [12218182.001]
  • [Cites] J Cell Biol. 1998 Nov 30;143(5):1155-66 [9832546.001]
  • [Cites] J Virol. 1999 Mar;73(3):2469-80 [9971832.001]
  • [Cites] Mol Biol Cell. 1999 Jun;10(6):1821-36 [10359599.001]
  • [Cites] Mol Biol Cell. 1999 Sep;10(9):2803-15 [10473628.001]
  • [Cites] J Virol. 2002 Dec;76(24):12866-76 [12438612.001]
  • [Cites] J Virol. 2003 Jan;77(1):167-78 [12477822.001]
  • [Cites] J Virol. 2003 Jan;77(2):963-9 [12502812.001]
  • [Cites] J Virol. 2003 Jan;77(2):1281-91 [12502845.001]
  • [Cites] J Virol. 2003 Feb;77(3):1977-83 [12525631.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] Mol Biol Cell. 2003 Mar;14(3):926-38 [12631714.001]
  • [Cites] Drug Discov Today. 2003 Apr 1;8(7):287-91 [12654538.001]
  • [Cites] J Virol. 2003 Apr;77(8):4722-30 [12663779.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] J Virol. 2003 Jun;77(11):6520-7 [12743308.001]
  • [Cites] J Virol. 2003 Jun;77(12):7067-77 [12768026.001]
  • [Cites] J Virol. 2003 Aug;77(16):8801-11 [12885899.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9280-5 [12883000.001]
  • [Cites] Virology. 2003 Aug 1;312(2):295-305 [12919735.001]
  • [Cites] J Virol. 2003 Oct;77(19):10645-50 [12970449.001]
  • [Cites] Annu Rev Biochem. 2003;72:175-207 [14527322.001]
  • [Cites] Nature. 1981 Jan 29;289(5796):366-73 [7464906.001]
  • [Cites] Virology. 1986 Dec;155(2):484-97 [3788061.001]
  • [Cites] J Virol. 1990 Oct;64(10):5106-13 [2168989.001]
  • [Cites] J Virol. 1991 Apr;65(4):1916-28 [1848311.001]
  • [Cites] J Biol Chem. 1993 Jan 25;268(3):1716-22 [8420949.001]
  • [Cites] FEBS Lett. 1993 Feb 22;318(1):71-6 [8436229.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Biol Chem. 1994 Jan 7;269(1):21-4 [8276796.001]
  • [Cites] J Virol. 1994 May;68(5):3220-31 [8151784.001]
  • [Cites] J Virol. 1995 Dec;69(12):7410-5 [7494245.001]
  • [Cites] J Biol Chem. 1995 Dec 8;270(49):29279-85 [7493959.001]
  • (PMID = 15254191.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI022470; United States / NIAID NIH HHS / AI / AI22470
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Protein Subunits; 0 / Receptors, Virus; 0 / Retroviridae Proteins
  • [Other-IDs] NLM/ PMC446138
  •  go-up   go-down






Advertisement